跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
依乐韦 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Zanamivir Powder for Inhalation
Approved
化学药品
Zanamivir Powder for Inhalation
GLAXOSMITHKLINE AUSTRALIA PTY LTD
🇨🇳 National Medical Products Administration
Approval Date
Jul 22, 2019
Approval ID
7MazXbwHeJF
Company
GLAXOSMITHKLINE AUSTRALIA PTY LTD
Type
化学药品
Approval Details
Approval Id
7MazXbwHeJF
Approval Number
H20140463
Generic Name
扎那米韦吸入粉雾剂
Generic Name En
Zanamivir Powder for Inhalation
Trade Name
依乐韦
Brand Name
依乐韦
Drug Type
化学药品
Dosage Form
吸入粉雾剂
Strength
5mg(以C12H20N4O7计)
Reg Date
2019-07-22
Expired Date
2024-07-21
Company Name
GLAXOSMITHKLINE AUSTRALIA PTY LTD
Company Address
1061 Mountain Highway Boronia VIC 3155 Australia
Production Company Name
GLAXOSMITHKLINE AUSTRALIA PTY LTD
Production Company Address
1061 Mountain Highway Boronia VIC 3155 Australia
Company Detail Path
/organization/glaxosmithkline-australia-pty-ltd
Production Company Detail Path
/organization/glaxosmithkline-australia-pty-ltd
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jul 22, 2019
Approval ID
7MazXbwHeJF
Type
化学药品
Back to NMPA Approvals